4 news items
Ligand Reports First Quarter 2024 Financial Results
AMGN
CASI
JAZZ
7 May 24
the leadership of Scott Plesha as Chief Executive Officer. Pelthos is focused on the commercialization of innovative, safe, and efficacious therapeutic products
Ligand Pharmaceuticals Announces Launch Of Pelthos Therapeutics To Accelerate Commercialization Of ZELSUVMI, Scott Plesha Named CEO
LGND
3 Apr 24
is committed to commercializing innovative, safe, and efficacious therapeutic products to help patients impacted by diseases with limited treatment options
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMIâ„¢
LGND
3 Apr 24
(Photo: Business Wire)
Pelthos is committed to commercializing innovative, safe, and efficacious
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
ALDX
LGND
MRK
27 Feb 24
to acquire; Ligand may not be able to create future revenues and cash flows through the acquisition of royalties or by developing innovative
- Prev
- 1
- Next